# OnCo record paper-casulo-pod24-follicular-lymphoma-jco-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-casulo-pod24-follicular-lymphoma-jco-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-casulo-pod24-follicular-lymphoma-jco-2015" ;
  schema:name "Early relapse of follicular lymphoma after R-CHOP defines patients at high risk for death: an analysis from the National LymphoCare Study"@en ;
  schema:alternateName "Casulo 2015"@en, "POD24"@en, "Progression of disease within 24 months in follicular lymphoma"@en ;
  schema:description "One in five people whose follicular lymphoma came back within two years of first treatment had half the five-year survival of everyone else, which is why that two-year mark now changes the plan."@en ;
  schema:url <https://onco.cc/key-papers/paper-casulo-pod24-follicular-lymphoma-jco-2015/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2014.59.7534>, <https://pubmed.ncbi.nlm.nih.gov/26124482/>, <https://europepmc.org/article/MED/26124482> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2014.59.7534> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Casulo C, Byrtek M, Dawson KL, et al." ;
  onco:related <https://onco.cc/key-papers/paper-prima-final-rituximab-maintenance-follicular-jco-2019/>, <https://onco.cc/key-papers/paper-elara-tisagenlecleucel-follicular-nat-med-2022/>, <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/prednisone/> ;
  onco:terms <https://onco.cc/terms/flipi/>, <https://onco.cc/terms/lymphoma-tx-pod24/>, <https://onco.cc/terms/r-chop/> ;
  onco:trials <https://onco.cc/trials/elara/>, <https://onco.cc/trials/zuma-5/>, <https://onco.cc/trials/mosun-len-mzl/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-biomarker-validation/>, <https://onco.cc/bottlenecks/b-trial-design/> ;
  onco:journals <https://onco.cc/journals/jco/> .